Takeda Pharmaceutical Company Limited (VIE:TKD)

VIE:TKD Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 3, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Cap	48,758	256	238	280	248	312
Market Cap Growth	16.27%	7.37%	-14.93%	13.07%	-20.63%	20.72%
Enterprise Value	74,894	255.88	24,140	21,216	19,225	20,196
PE Ratio	79.48	66.32	46.15	21.67	23.91	16.93
PS Ratio	2.01	0.01	0.01	0.01	0.01	0.02
PB Ratio	1.17	-	0.01	0.01	0.01	0.01
P/TBV Ratio	-	-	-	0.01	0.01	0.01
P/FCF Ratio	8.88	0.05	0.08	0.06	0.05	0.06
P/OCF Ratio	7.55	0.04	0.06	0.05	0.04	0.06
EV/Sales Ratio	3.06	0.01	1.04	0.96	0.99	1.16
EV/EBITDA Ratio	10.34	0.04	4.14	3.18	3.20	3.38
EV/EBIT Ratio	22.75	0.14	23.49	7.92	7.63	7.25
EV/FCF Ratio	13.64	0.05	8.16	4.64	3.52	4.11
Debt / Equity Ratio	0.63	-	0.67	0.69	0.76	0.90
Debt / EBITDA Ratio	8.00	-	4.54	3.60	3.96	4.24
Debt / FCF Ratio	-	-	8.96	5.24	4.35	5.15
Net Debt / Equity Ratio	0.54	-	0.60	0.60	0.61	0.70
Net Debt / EBITDA Ratio	6.74	-	4.10	3.14	3.16	3.32
Net Debt / FCF Ratio	-	-	8.08	4.58	3.47	4.04
Asset Turnover	0.30	0.61	0.29	0.30	0.27	0.25
Inventory Turnover	1.17	2.61	1.30	1.35	1.38	1.31
Quick Ratio	0.58	-	0.48	0.50	0.75	1.02
Current Ratio	1.19	-	1.06	0.97	1.21	1.53
Return on Equity (ROE)	4.52%	2.97%	2.12%	5.27%	4.24%	7.60%
Return on Assets (ROA)	4.77%	6.27%	-3.12%	4.16%	4.38%	3.85%
Return on Invested Capital (ROIC)	5.36%	6.98%	-3.51%	4.79%	5.09%	4.40%
Return on Capital Employed (ROCE)	4.70%	5.40%	1.56%	4.35%	4.16%	4.68%
Earnings Yield	1.26%	1.51%	2.17%	4.61%	4.18%	5.91%
FCF Yield	11.26%	1829.87%	1241.02%	1632.60%	2206.42%	1575.87%
Dividend Yield	3.81%	0.00%	0.00%	4.11%	5.20%	4.48%
Payout Ratio	277.04%	280.54%	199.34%	88.14%	123.30%	75.36%
Buyback Yield / Dilution	-	110.81%	5.34%	52.56%	171.09%	3.75%
Total Shareholder Return	-	110.81%	5.34%	56.67%	176.29%	8.23%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.